- Home
- RNXT vs WAI Comparison
RNXT vs WAI Comparison
Compare RNXT & WAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RNXT
- WAI
- Stock Information
- Founded
- RNXT 2012
- WAI 2018
- Country
- RNXT United States
- WAI China
- Employees
- RNXT N/A
- WAI N/A
- Industry
- RNXT Biotechnology: Pharmaceutical Preparations
- WAI
- Sector
- RNXT Health Care
- WAI
- Exchange
- RNXT Nasdaq
- WAI NYSE
- Market Cap
- RNXT 44.6M
- WAI 40.5M
- IPO Year
- RNXT 2021
- WAI 2023
- Fundamental
- Price
- RNXT $1.30
- WAI $0.48
- Analyst Decision
- RNXT Strong Buy
- WAI
- Analyst Count
- RNXT 2
- WAI 0
- Target Price
- RNXT $7.25
- WAI N/A
- AVG Volume (30 Days)
- RNXT 135.9K
- WAI 1.8M
- Earning Date
- RNXT 08-12-2025
- WAI 08-24-2025
- Dividend Yield
- RNXT N/A
- WAI N/A
- EPS Growth
- RNXT N/A
- WAI N/A
- EPS
- RNXT N/A
- WAI N/A
- Revenue
- RNXT $240,000.00
- WAI $3,750,352.00
- Revenue This Year
- RNXT $3,104.65
- WAI N/A
- Revenue Next Year
- RNXT $301.89
- WAI N/A
- P/E Ratio
- RNXT N/A
- WAI N/A
- Revenue Growth
- RNXT N/A
- WAI N/A
- 52 Week Low
- RNXT $0.75
- WAI $0.44
- 52 Week High
- RNXT $1.69
- WAI $20.00
- Technical
- Relative Strength Index (RSI)
- RNXT 53.41
- WAI N/A
- Support Level
- RNXT $1.29
- WAI N/A
- Resistance Level
- RNXT $1.38
- WAI N/A
- Average True Range (ATR)
- RNXT 0.07
- WAI 0.00
- MACD
- RNXT -0.01
- WAI 0.00
- Stochastic Oscillator
- RNXT 48.39
- WAI 0.00
About RNXT RenovoRx Inc.
RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.
About WAI TOP KINGWIN LTD
Top KingWin Ltd operates as a corporate business training and consulting company, providing personal and management training and financial consulting services. It provides some essential business services in China to young and emerging companies, including corporate business training services, which mainly focus on knowledge and new perspectives on the capital markets; corporate consulting services, which mainly focus on various aspects of fundraising; and advisory and transaction services. Its main clients are entrepreneurs and executives in China's small and medium enterprises (SMEs).